Bench Press for Aug. 21, 2020 Mechanisms of retinopathy come into focus Researchers at the University of Montreal have linked the formation of neutrophil extracellular traps (NETs) to beneficial remodeling of vasculature in retinal diseases. In the developed world, the major causes of blindness lead to deregulated blood vessel growth in the retina. Sometimes such […]

John Gordon Freund Sells 500000 Shares of Sutro Biopharma Inc (NASDAQ:STRO) Stock Sutro Biopharma Inc (NASDAQ:STRO) Director John Gordon Freund sold 500,000 shares of Sutro Biopharma stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $8.72, for a total value of $4,360,000.00. The transaction was disclosed in […]

Fareed Bruintjies – Plasma Cell Cancer: Multiple Myeloma With his diagnosis carrying a median survival rate of four years, Fareed shares his health story of dealing with incurable cancer.

Plasma Cell Dyscrasia and the Kidney – Fellow's Core Curriculum Recorded during COVID19 2020 pandemic, fellow’s core curriculum.

FDA Approves Daratumumab Plus Kd Regimen in Relapsed/Refractory Multiple Myeloma The FDA granted approval to the combination of daratumumab (Darzalex) plus carfilzomib (Kyprolis) and dexamethasone (DKd) as treatment of adult patients with relapsed or refractory multiple myeloma who have received up to 3 prior lines of therapy, Genmab A/S announced in a press release.1 The approval […]

One in three Covid fatalities suffered chronic kidney illness MARGAO: Nearly every third person who died at the ESI-Covid hospital, Margao until July 31 was a case of a chronic kidney disease, statistics reveal. Of the 35 deaths that occurred during this period, 10 were of those who had a kidney disease as a co-morbidity, […]

Surviving Multiple Myeloma – Mayo Clinic Multiple myeloma is a type of cancer for which there is no cure. But treatment for this disease has improved greatly in recent years. Patients can live in remission for a long time. The man you’re about to meet was diagnosed with multiple myeloma last year, and after an […]

Dr. Wong on the Potential Role of Venetoclax in Relapsed/Refractory AL Amyloidosis Sandy Wong, MD, discusses the potential role of venetoclax in relapsed/refractory light chain amyloidosis. Sandy Wong, MD, assistant professor, University of California, San Francisco (UCSF) School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the potential role of venetoclax (Venclexta) in […]

Clinical Trials Are Pivotal in the Evolution of CAR-T Cell Therapy in Multiple Myeloma While the use of CAR-T cell therapy is currently still being investigated in patients with multiple myeloma, Dr. Nina Shah of the UCSF Helen Diller Family Comprehensive Cancer Center believes that these clinical trials will be what ultimately moves the field […]

Blood Cancer Drugs Market Size, Share, Growth, Trends, and Forecast, 2019 to 2023 Global “Blood Cancer Drugs market”- Report defines the vital growth factors, opportunities and market segment of top players during the forecast period from 2019 to 2025. The report Blood Cancer Drugs offers a complete market outlook and development rate during the past, […]